205 related articles for article (PubMed ID: 37922327)
21. Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis.
Pradhan AK; Modi J; Maji S; Kumar A; Bhoopathi P; Mannangatti P; Guo C; Afosah DK; Mochel MC; Mukhopadhyay ND; Kirkwood JM; Wang XY; Desai UR; Sarkar D; Emdad L; Das SK; Fisher PB
Mol Cancer Ther; 2023 Oct; 22(10):1115-1127. PubMed ID: 37721536
[TBL] [Abstract][Full Text] [Related]
22. mda-9/Syntenin: more than just a simple adapter protein when it comes to cancer metastasis.
Sarkar D; Boukerche H; Su ZZ; Fisher PB
Cancer Res; 2008 May; 68(9):3087-93. PubMed ID: 18451132
[TBL] [Abstract][Full Text] [Related]
23. MDA-9/syntenin: a positive gatekeeper of melanoma metastasis.
Das SK; Bhutia SK; Kegelman TP; Peachy L; Oyesanya RA; Dasgupta S; Sokhi UK; Azab B; Dash R; Quinn BA; Kim K; Barral PM; Su ZZ; Boukerche H; Sarkar D; Fisher PB
Front Biosci (Landmark Ed); 2012 Jan; 17(1):1-15. PubMed ID: 22201728
[TBL] [Abstract][Full Text] [Related]
24. Potential Therapeutic Applications of MDA-9/Syntenin-NF-κB-RKIP Loop in Human Liver Carcinoma.
Notarbartolo M; Labbozzetta M; Pojero F; D'Alessandro N; Poma P
Curr Mol Med; 2018; 18(9):630-639. PubMed ID: 30608040
[TBL] [Abstract][Full Text] [Related]
25. Raf kinase inhibitor RKIP inhibits MDA-9/syntenin-mediated metastasis in melanoma.
Das SK; Bhutia SK; Sokhi UK; Azab B; Su ZZ; Boukerche H; Anwar T; Moen EL; Chatterjee D; Pellecchia M; Sarkar D; Fisher PB
Cancer Res; 2012 Dec; 72(23):6217-26. PubMed ID: 23066033
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of stromal syntenin sustains AML development.
Leblanc R; Ghossoub R; Goubard A; Castellano R; Fares J; Camoin L; Audebert S; Balzano M; Bou-Tayeh B; Fauriat C; Vey N; Garciaz S; Borg JP; Collette Y; Aurrand-Lions M; David G; Zimmermann P
EMBO Mol Med; 2023 Nov; 15(11):e17570. PubMed ID: 37819151
[TBL] [Abstract][Full Text] [Related]
27. MDA-9/syntenin is a key regulator of glioma pathogenesis.
Kegelman TP; Das SK; Hu B; Bacolod MD; Fuller CE; Menezes ME; Emdad L; Dasgupta S; Baldwin AS; Bruce JN; Dent P; Pellecchia M; Sarkar D; Fisher PB
Neuro Oncol; 2014 Jan; 16(1):50-61. PubMed ID: 24305713
[TBL] [Abstract][Full Text] [Related]
28. Syntenin: a novel PDZ domain-containing scaffolding protein associated with human melanoma metastasis.
Yang JB; McCarthy JB
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Apr; 32(2):204-12. PubMed ID: 17478924
[TBL] [Abstract][Full Text] [Related]
29. Recombinant MDA-7/IL24 Suppresses Prostate Cancer Bone Metastasis through Downregulation of the Akt/Mcl-1 Pathway.
Pradhan AK; Bhoopathi P; Talukdar S; Shen XN; Emdad L; Das SK; Sarkar D; Fisher PB
Mol Cancer Ther; 2018 Sep; 17(9):1951-1960. PubMed ID: 29934341
[TBL] [Abstract][Full Text] [Related]
30. Activation of the integrin effector kinase focal adhesion kinase in cancer cells is regulated by crosstalk between protein kinase Calpha and the PDZ adapter protein mda-9/Syntenin.
Hwangbo C; Kim J; Lee JJ; Lee JH
Cancer Res; 2010 Feb; 70(4):1645-55. PubMed ID: 20145126
[TBL] [Abstract][Full Text] [Related]
31. Expression patterns of MDA-9/syntenin during development of the mouse embryo.
Jeon HY; Das SK; Dasgupta S; Emdad L; Sarkar D; Kim SH; Lee SG; Fisher PB
J Mol Histol; 2013 Apr; 44(2):159-66. PubMed ID: 23180153
[TBL] [Abstract][Full Text] [Related]
32. MDA-9/syntenin interacts with ubiquitin via a novel ubiquitin-binding motif.
Okumura F; Yoshida K; Liang F; Hatakeyama S
Mol Cell Biochem; 2011 Jun; 352(1-2):163-72. PubMed ID: 21359963
[TBL] [Abstract][Full Text] [Related]
33. mda-9/Syntenin protein positively regulates the activation of Akt protein by facilitating integrin-linked kinase adaptor function during adhesion to type I collagen.
Hwangbo C; Park J; Lee JH
J Biol Chem; 2011 Sep; 286(38):33601-12. PubMed ID: 21828040
[TBL] [Abstract][Full Text] [Related]
34. MiRNA-139-3p inhibits the proliferation, invasion, and migration of human glioma cells by targeting MDA-9/syntenin.
Tian W; Wu W; Li X; Rui X; Wu Y
Biochem Biophys Res Commun; 2019 Jan; 508(1):295-301. PubMed ID: 30502089
[TBL] [Abstract][Full Text] [Related]
35. GRP78 modulates cell adhesion markers in prostate Cancer and multiple myeloma cell lines.
Cultrara CN; Kozuch SD; Ramasundaram P; Heller CJ; Shah S; Beck AE; Sabatino D; Zilberberg J
BMC Cancer; 2018 Dec; 18(1):1263. PubMed ID: 30563499
[TBL] [Abstract][Full Text] [Related]
36. MDA-9/Syntenin regulates protective autophagy in anoikis-resistant glioma stem cells.
Talukdar S; Pradhan AK; Bhoopathi P; Shen XN; August LA; Windle JJ; Sarkar D; Furnari FB; Cavenee WK; Das SK; Emdad L; Fisher PB
Proc Natl Acad Sci U S A; 2018 May; 115(22):5768-5773. PubMed ID: 29760085
[TBL] [Abstract][Full Text] [Related]
37. Syntenin-1 is a promoter and prognostic marker of head and neck squamous cell carcinoma invasion and metastasis.
Cui L; Cheng S; Liu X; Messadi D; Yang Y; Hu S
Oncotarget; 2016 Dec; 7(50):82634-82647. PubMed ID: 27811365
[TBL] [Abstract][Full Text] [Related]
38. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr Virus LMP1 Promotes Syntenin-1- and Hrs-Induced Extracellular Vesicle Formation for Its Own Secretion To Increase Cell Proliferation and Migration.
Nkosi D; Sun L; Duke LC; Patel N; Surapaneni SK; Singh M; Meckes DG
mBio; 2020 Jun; 11(3):. PubMed ID: 32546618
[TBL] [Abstract][Full Text] [Related]
40. Acidic extracellular pH promotes prostate cancer bone metastasis by enhancing PC-3 stem cell characteristics, cell invasiveness and VEGF-induced vasculogenesis of BM-EPCs.
Huang S; Tang Y; Peng X; Cai X; Wa Q; Ren D; Li Q; Luo J; Li L; Zou X; Huang S
Oncol Rep; 2016 Oct; 36(4):2025-32. PubMed ID: 27498716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
